More on BIOA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $24.84 |
|
|||
| Open | $24.88 | ||||
| 52 Wk High | $8.73 | ||||
| 52 Wk Low | $2.86 | ||||
| Day High | $24.93 | ||||
| Day Low | $23.39 | ||||
| P/E | N/A | ||||
| EPS | $-3.82 | ||||
| Volume | 380,847 | ||||
- Form 4 BioAge Labs, Inc. For: Jun 29 Filed by: Barton Shane
- Form 144 BioAge Labs, Inc. Filed by: Barton Shane
- New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
- Form 144 BioAge Labs, Inc. Filed by: Barton Shane
- BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology
- BioAge Labs begins Phase 2 trial of NLRP3 inhibitor BGE-102
- BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
- Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Pande Vijay Satyanand
- Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: Hemrajani Rekha
- Form 4 BioAge Labs, Inc. For: Jun 10 Filed by: HEALY JAMES
Entities mentioned with BIOA
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Tesla | View Related Stories »
- Show More...
